Charles K. Gayer

Vice President and CCO, BioCryst Pharmaceuticals.

Companies

BioCryst PharmaceuticalsPresident Dec 16, 2025 to now¹
BioCryst PharmaceuticalsVice President and CCO Jan 21, 2020 to Dec 23, 2024²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 22, 2025Exercised options 50,000 shares at $5.51 of BioCryst Pharmaceuticals³
Dec 22, 2025Exercised options 10,091 shares at $5.04 of BioCryst Pharmaceuticals³
Dec 22, 2025Exercised options 14,142 shares at $3.22 of BioCryst Pharmaceuticals³
Dec 19, 2025Shares withheld for tax 11,477 shares at $7.41 of BioCryst Pharmaceuticals³
Dec 17, 2025Granted 471,000 shares of BioCryst Pharmaceuticals⁴
Dec 12, 2025Shares withheld for tax 8,181 shares at $7.57 of BioCryst Pharmaceuticals⁵
Dec 19, 2024Shares withheld for tax 2,461 shares at $7.39 of BioCryst Pharmaceuticals⁶
Dec 19, 2024Granted 125,950 shares of BioCryst Pharmaceuticals⁶
Dec 14, 2024Shares withheld for tax 8,251 shares at $7.53 of BioCryst Pharmaceuticals⁷
May 13, 2024Bought 30,000 shares at $5.47 of BioCryst Pharmaceuticals⁸
Dec 19, 2023Shares withheld for tax 2,482 shares at $6.05 of BioCryst Pharmaceuticals⁹
Dec 14, 2023Shares withheld for tax 5,840 shares at $6.43 of BioCryst Pharmaceuticals¹⁰
Dec 14, 2023Granted 34,000 shares of BioCryst Pharmaceuticals¹⁰
Dec 19, 2022Granted 34,000 shares of BioCryst Pharmaceuticals¹¹
Dec 15, 2022Sold 6,100 shares at $10.90 of BioCryst Pharmaceuticals¹²
Dec 14, 2021Granted 125,000 shares of BioCryst Pharmaceuticals¹³
Dec 14, 2021Granted 80,000 shares of BioCryst Pharmaceuticals¹⁴

The numbers on this page point here. Each one links to the record it came from.